People in the News
Sirna Therapeutics said this week that it has named Gregory Weaver as CFO.
Weaver replaces Martin Schmieg, who resigned from the company last year.
According to Sirna, Weaver most recently served as CFO of Nastech Pharmaceutical. Before that, he was CFO of Ilex Oncology. He has a BS from Trinity University and an MBA from Boston College Graduate School of Management.
Alnylam Pharmaceuticals said this week that Akshay Vaishnaw has become the company's vice president of clinical research.
Vaishnaw comes to Alnylam from Biogen Idec, where he was most recently senior director of translational medicine. He holds an MD from the University of Wales College of Medicine, a PhD from the University of London, and an executive MBA from Harvard Business School.
Benitec this week named two new directors.
The company said Peter Francis, a partner at the Australian law firm of Francis Abourizk Lightowlers, has been appointed as a non-executive director.
Additionally, Michael Catelani, the company's CFO, has been appointed as an executive director.
Products & Services
Sigma-Aldrich has recently introduced the Mission TRC shRNA human tumor suppressor gene family, an shRNA gene family set in lentiviral format.
The suppressors are also available as bacterial glycerol stocks, the company said.